Company Filing History:
Years Active: 1992-1994
Title: Jack B Jiang: Innovator in Protein Kinase C Inhibition
Introduction
Jack B Jiang is a prominent inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit protein kinase C. With a total of 5 patents to his name, Jiang's work is pivotal in addressing various medical conditions.
Latest Patents
Jiang's latest patents include innovative compounds such as 1,3-dioxane derivatives that exhibit protein kinase C inhibitory activity. These compounds are designed to treat conditions related to cancer tumors, inflammatory diseases, reperfusion injury, and cardiac dysfunctions. Another notable patent involves bis-(hydroxylakylamino)-anthraquinone inhibitors, which also target protein kinase C and aim to provide therapeutic benefits for similar medical conditions.
Career Highlights
Jack B Jiang is currently associated with Sphinx Pharmaceuticals Corporation, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on cancer treatment and other serious health issues.
Collaborations
Jiang collaborates with esteemed colleagues, including Mary George Johnson and Jeffrey B Nichols, to further enhance the scope and effectiveness of his research.
Conclusion
Jack B Jiang's innovative contributions to the field of protein kinase C inhibition highlight his dedication to improving medical treatments. His patents reflect a commitment to addressing critical health challenges through scientific advancement.